Interphex Japan 2027
INTERPHEX Week Tokyo is RX Japan's exhibition for pharmaceutical and biopharma manufacturing, made up of six specialist shows from packaging to CDMO services. It draws pharma production, R&D and quality staff and their suppliers.
Wednesday to Friday · 3 days
Organizer
Published by the organizer
Every year
How often it's held
Checked October 19, 2026
Reported attendance
25,321
daily visitors summed · 2026
Reported exhibitors
784 exhibitors · 2026
About Interphex Japan 2027
Interphex Japan is RX Japan's trade show for pharmaceutical and biotech manufacturing, run as INTERPHEX Week Tokyo. It groups six specialist shows, from packaging machinery to APIs, lab tools and CDMO services, beside Regenerative Medicine Expo Tokyo. The next edition runs 30 June to 2 July 2027 at Tokyo Big Sight. The 2026 edition at Makuhari Messe drew 784 exhibitors and 25,321 visits over three days. It's built for pharma production, R&D, quality and purchasing staff and the suppliers who sell to them.
126
Overseas exhibitors
15
Exhibiting countries and regions
38
Visitors' countries and regions
9,522
Seminar attendances (three days)
670
Networking party participants
900+
Exhibitors (forecast)
What happens at Interphex Japan
Interphex Japan is a week of six co-located specialist shows plus a regenerative medicine expo. The show outline names INTERPHEX JAPAN for manufacturing and packaging and in-PHARMA JAPAN for APIs and ingredients. BioPharma EXPO, PharmaLab EXPO for drug discovery, Pharma Digital Transformation EXPO and CMO/CDMO EXPO complete the six.
Regenerative Medicine Expo Tokyo runs alongside. Its exhibit profile covers culture media, reagents, incubators, cell processing centers and contract services. The visitor page promotes live demos of filling machines, packaging robots and cleanroom systems.
A conference runs next to the floor. For 2026 the organizer published 320 sessions across organizer conferences, exhibitor seminars and an academic forum. Of those, 47 sessions offered smartphone AI translation. The 2026 post-show report counted 9,522 seminar attendances over three days.
The same report lists a networking party with 670 participants. A hosted buyer program brought 13 major pharma companies from Korea, China and Taiwan on guided booth tours. The official site links a global INTERPHEX series that includes INTERPHEX and BIOPLUS-INTERPHEX KOREA.
Related pharma shows on this site include CPhI Japan and CPhI Middle East.
What's new for Interphex Japan 2027
The biggest change for 2027 is the venue and season. The show moves to Tokyo Big Sight for 30 June to 2 July, after a May 2026 run at Makuhari Messe. CMO/CDMO EXPO returns for its second edition and Pharma Digital Transformation EXPO for its third, per the upcoming shows page of the post-show report.
Who attends Interphex Japan
Interphex Japan draws drug makers, their suppliers and distributors, mostly from sales, R&D and production roles. In the 2026 visitor profile, pharmaceutical and diagnostic drug makers were the largest industry group at 23.8%. Trading companies and distributors made up 13.1%, and machinery and component makers 12.5%.
- Pharmaceutical / Diagnostic Drug Manufacturers23.8%
- Others15.7%
- Trading Companies / Distributors13.1%
- Machinery / Component Manufacturers12.5%
- Chemical Manufacturers9.1%
- Construction / Engineering7.9%
- Cosmetics Manufacturers5%
- IT / Software3.1%
- Regenerative Medicine Companies2.6%
- Logistics2.3%
Top 10 of 13 categories in the 2026 post-show report, including the concurrent shows.2026 · interphex.jp ↗
- Sales / Marketing30.8%
- Research / Development19.3%
- Manufacturing / Production Engineering13.8%
- Management / Administration9.2%
- Others8.1%
- Quality Control / Quality Assurance5.3%
- Facilities / Equipment4%
- Purchasing3%
- Business Development / Licensing2.8%
- Logistics1.2%
Top 10 of 12 categories in the 2026 post-show report. Digital Transformation (1.2%) and Information Systems (1.0%) aren't shown.2026 · interphex.jp ↗
- 20 May7,511
- 21 May8,445
- 22 May9,365
Each person counts once per day, so the 25,321 total counts multi-day visitors more than once. Excludes exhibitors and press.2026 · interphex.jp ↗
Chemical makers were 9.1%, construction and engineering firms 7.9%, and cosmetics makers 5.0%. By job function, sales and marketing staff led with 30.8%. Research and development followed at 19.3%, then manufacturing and production engineering at 13.8%. Management made up 9.2%, quality control and assurance 5.3%, and purchasing 3.0%.
Visitors came from 38 countries and regions in 2026. The organizer counted 25,321 visits over three days, including the concurrent shows. That total sums each day's visitors, so someone who came on two days counts twice. Exhibitors and press aren't included.
For 2025, an organizer release reported 33,681 visitors and 902 exhibitors. It doesn't say how those visitors were counted. The exhibit page names past Tokyo visitors such as Takeda Pharmaceutical, Astellas Pharma, Daiichi Sankyo, Shiseido, Novartis and Sanofi. It doesn't give the year.
Attendance and exhibitors by year
As the organizer reports them. What's counted varies between events, so compare with care.
| Edition | Attendance | Exhibitors |
|---|---|---|
| 2026 | 25,321daily visitors summed over three days (a person attending two days counts twice), including Regenerative Medicine Expo Tokyo, excluding exhibitors and pressThe 2026 edition ran at Makuhari Messe.interphex.jp ↗ | 784 exhibitorsinterphex.jp ↗ |
| 2025 | 33,681visitors, as stated in an organizer release (counting method not given)interphex.jp ↗ | 902 exhibitorsinterphex.jp ↗ |
Companies at Interphex Japan 2026
The named companies below exhibited at the 2026 edition, because RX Japan hasn't published a 2027 exhibitor directory yet. The 2026 post-show report lists every exhibitor by show.
Partners (1)Japan Pharmaceutical Manufacturers Association
Exhibitors (29)Syntegon Technology K.K., Stevanato Group S.p.A., Marchesini Group S.p.A. and 26 more
- Syntegon Technology K.K. · 2026INTERPHEX JAPAN section
- Stevanato Group S.p.A. · 2026Booth 33-6, development and integrated solutions for combination products
- Marchesini Group S.p.A. · 2026INTERPHEX JAPAN section
- Bausch+Ströbel SE + Co KG · 2026INTERPHEX JAPAN section
- OPTIMA pharma GmbH · 2026INTERPHEX JAPAN section
- SKAN JAPAN K.K. · 2026INTERPHEX JAPAN section
- Hitachi, Ltd. · 2026INTERPHEX JAPAN section
- TOPPAN Inc. · 2026INTERPHEX JAPAN section
- Terumo Corporation · 2026INTERPHEX JAPAN section
- Mettler-Toledo K.K. · 2026INTERPHEX JAPAN and PharmaLab EXPO sections
- FUJIFILM Wako Pure Chemical Corporation · 2026in-PHARMA JAPAN, pharmaceutical raw materials, oligonucleotide reagents, contract manufacturing
- Roquette Japan K.K. · 2026in-PHARMA JAPAN section
- Cytiva · 2026BioPharma EXPO section
- Sartorius Stedim Japan K.K. · 2026BioPharma EXPO section
- Merck Ltd. · 2026BioPharma EXPO section
- Thermo Fisher Scientific K.K. · 2026BioPharma EXPO and PharmaLab EXPO sections
- Agilent Technologies Japan, Ltd. · 2026PharmaLab EXPO section
- KNF Japan Co., Ltd. · 2026Booth 6-48, LABOPORT diaphragm vacuum pumps
- Fujitsu Limited · 2026Pharma Digital Transformation EXPO section
- KEYENCE CORPORATION · 2026Pharma Digital Transformation EXPO section
- Rockwell Automation Japan Co., Ltd. · 2026Pharma Digital Transformation EXPO section
- AGC Biologics · 2026CMO/CDMO EXPO section
- Boehringer Ingelheim Bio Pharmaceuticals GmbH · 2026CMO/CDMO EXPO section
- Catalent Japan K.K. · 2026CMO/CDMO EXPO section
- Almac Group · 2026CMO/CDMO EXPO section
- Wuxi Biologics CO., LTD. · 2026CMO/CDMO EXPO section
- Takara Bio Inc. · 2026Regenerative Medicine EXPO section
- PHC Corporation · 2026Regenerative Medicine EXPO section
- Charles River Laboratories Japan G.K. · 2026Regenerative Medicine EXPO section
Attending (6)Takeda Pharmaceutical, Astellas Pharma, Daiichi Sankyo and 3 more
- Takeda PharmaceuticalNamed in the organizer's list of past Tokyo Show visitors (year not given)
- Astellas PharmaNamed in the organizer's list of past Tokyo Show visitors (year not given)
- Daiichi SankyoNamed in the organizer's list of past Tokyo Show visitors (year not given)
- ShiseidoNamed in the organizer's list of past Tokyo Show visitors (year not given)
- NovartisNamed in the organizer's list of past Tokyo Show visitors (year not given)
- SanofiNamed in the organizer's list of past Tokyo Show visitors (year not given)
Global equipment makers filled INTERPHEX JAPAN, while life science suppliers took BioPharma EXPO and PharmaLab EXPO. Contract manufacturers made up the new CMO/CDMO EXPO. A few companies also announced their stands on their own sites.
Exhibitors at Interphex Japan
The 2026 edition had 784 exhibitors, including 126 from overseas, according to the post-show report. They came from 15 countries and regions. That's down from 902 exhibitors from 20 countries in 2025. Before the 2026 show, the organizer had expected around 950 exhibitors.
For 2027, the official site forecasts 900+ exhibitors, 30,000+ visitors and 320+ sessions. It labels these figures as forecasts.
To exhibit, companies send the exhibiting information request form. Stands are sold first come, first served, with no fixed deadline, per the exhibiting FAQ. Costs depend on stand size and build. Rental display packages include basic furniture, electrics and construction.
RX Japan doesn't publish stand prices online. It sends a cost estimate, the previous exhibitor list and an updated floor plan on request. Exhibitors may hand out leaflets and samples only inside their own booth.
Exhibitors capture leads by scanning the code on visitor badges, as the participation policy describes. The organizer's 2026 release mentions mobile app lead capture and visitor analytics. Compare lead retrieval apps if you want your own setup.
Sponsors and partners at Interphex Japan
Interphex Japan doesn't publish a sponsor list or a sponsorship prospectus. RX Japan instead sells featured placements, awards and seminar opportunities, per its 2026 exhibitor release.
INTERPHEX Week Tokyo is endorsed by the Japan Pharmaceutical Manufacturers Association, per the show outline. Regenerative Medicine Expo Tokyo is endorsed by the Japanese Society for Regenerative Medicine and the Forum for Innovative Regenerative Medicine.
In 2026, seminars ran with partners including the Japan Generic Medicines Association, the JAPAN CDMO Association and the Japanese Society for Process Chemistry. That's according to the post-show report. For planning packages, see event sponsorship software.
The event's tech
We couldn't identify a third-party registration platform on the event's website.
Interphex Japan attendee list, exhibitor list and sponsor list
Exhibitor list
Published
Sponsor list
Not published
Attendee list
Not published or sold
RX Japan publishes exhibitor lists but no attendee list. The 2026 exhibitor directory stays online. The 2026 post-show report prints the full exhibitor list by show.
The visitor FAQ says the next directory opens about three months before the show. There's no sponsor list. The 2026 floor map shows stand numbers for Makuhari Messe, so it doesn't reflect the 2027 layout.
Exhibitors only get visitor data when visitors let their badges be scanned, under the participation policy. For other routes, read how to find who's attending an event and compare event intelligence platforms.
See who's attending Interphex Japan
Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending
Speakers at Interphex Japan 2027
Interphex Japan hasn't announced its 2027 speakers yet. The conference page says the 2027 program comes out around mid-March.
Interphex Japan hasn't announced its 2027 speakers yet. Below is who spoke at past editions.
At the 2026 edition, the INTERPHEX Week keynote came from Daisuke Fujii of the Ministry of Health, Labour and Welfare. He spoke on government steps to secure a stable drug supply, per the 2026 post-show report. Toru Kimura, President and CEO of Sumitomo Pharma, gave the Regenerative Medicine Expo keynote on iPS cell products.
Other 2026 speakers came from Takeda, Astellas, Chugai, Daiichi Sankyo, Boehringer Ingelheim, Shiseido, AbbVie and Sanofi. Sessions covered GMP and quality, CDMO strategy, AI in drug discovery, pharma DX and cell therapy manufacturing. The 2026 conference program stays online.
The organizer lists a technical conference advisory committee with members from Astellas, Eisai, Shionogi, Takeda and engineering firms. There's no public call for papers. Exhibitors can buy presentation slots in the halls, per the exhibiting FAQ.
Who spoke at Interphex Japan 2026 (45)
- Daisuke Fujii, Director, Office of Pharmaceutical Industry and Venture Support Policy, Health Policy Bureau, Ministry of Health, Labour and Welfare
- Toru Kimura, Representative Director, President and CEO, Sumitomo Pharma Co., Ltd.
- Shingou Sakurai, Professor, Lab. of Pharmaceutical Quality Design and GMP, Faculty of Pharmaceutical Sciences, Tokyo University of Science
- Tomomi Kawamata, President, Japan Generic Medicines Association, Nissin Pharmaceutical Co., Ltd.
- Yuji Takeuchi, Executive Director, Japan CDMO Association / Senior Executive Director, Human Resources/Legal & General Affairs Div., Bushu Pharmaceuticals Ltd.
- Go Yamamoto, Director, Office of Compliance, Compliance and Narcotics Div., Pharmaceutical Safety Bureau, Ministry of Health, Labour and Welfare
- Keiji Seto, Director, R&D - R&D Strategy, Kao Corp.
- Martin Maus, Head of late oral product development, Global Development CMC NCE, Boehringer Ingelheim Pharma GmbH & Co. KG
- Yoshihiro Hagino, Vice President, Manufacturing & Technology Innovation Dept., Shiseido Co., Ltd.
- Makoto Ogawa, Chair, Policy Implementation Committee, Japan Generic Medicines Association / Director Officer of Administration Headquarters, Nissin Pharmaceutical Co., Ltd.
- Tetsuya Suehara, Quality Operations Lead, External Operations Japan/APAC, Global Manufacturing Quality, Takeda Pharmaceutical Co., Ltd.
- Tadao Takano, Chairman, Japan CDMO Association / President, Bushu Pharmaceuticals Ltd.
- Yutaka Takeuchi, Board Member, Japan CDMO Association / Advisor, Catalent Japan K.K.
- Michael Kraich, Head of Global Project and Product Management - BioXcellence, Boehringer Ingelheim Biopharmaceuticals GmbH
- Kose Michibuchi, General Manager, Life Science Div., Pharmaceuticals Dept., TOYOBO Co., Ltd.
- Rei Kobayashi, Head of Plant DX Group, Plant Management Dept. II, Daiichi Sankyo Co., Ltd.
- Nam-Gu Her, CEO, Aimed Bio, Inc.
- Yoriko Akashi, Deputy Director, Healthcare Industries Div., Commerce and Service Industry Policy Group, Ministry of Economy, Trade and Industry
- Shinichi Morioka, Head, Customer Excellence, Astellas Pharma Inc.
- Yukinobu Imai, Head, AI & Big Data, Data, Digital & technology Japan Pharma Business Unit, Takeda Pharmaceutical Co., Ltd.
- Hiroki Kaneko, Commercial Effectiveness Group Lead, Specialty Care Business Unit Alliance Immunology Franchise, Sanofi K.K.
- Hirotaka Matsuyama, HR Director, Head of HR Japan, AbbVie GK
- Yuki Maeda, Chief Editor, AnswersNews, QUICK Co., Ltd.
- Kenji Wada, Senior Research Scientist, Synthetic Organic Chemistry Labs., FUJIFILM Corporation
- Nobuhisa Fukuda, Corporate Officer, Senior Vice President, Deputy Head of Research & Development Div. (CMC), Sumitomo Pharma Co., Ltd.
- Koji Tamada, Professor and Chairman, Yamaguchi University
- Yousuke Watanabe, Head of API Process Development Dept. (Bioprocess), Chugai Pharmaceutical Co., Ltd.
- Hideo Yamaguchi, President & CEO, Cellafa Bioscience Inc. / Senior Vice President, Product Development & Manufacturing, Astellas Pharma Inc.
- Hiroyoshi Toyoshiba, Chief Science Officer, FRONTEO, Inc.
- Angela Davis, Senior Managing Executive Officer, Vice President, R&D Head, Japan, Bristol-Myers Squibb K.K.
- Kazumitsu Kanatani, Head of Digital Strategy Dept., Digital Transformation Unit, Chugai Pharmaceutical Co., Ltd.
- Jun Takami, General Manager, Japan Region / Business Manager, Yokohama Site, AGC Biologics
- Takeaki Kawashima, Senior Marketing Manager, BD Medical - Pharmaceutical Systems, Nippon Becton Dickinson Co., Ltd.
- Akira Kase, General Manager, Bio Business Div., FUJIFILM Toyama Chemical Co., Ltd.
- Ryo Ohashi, Associate Director, Formulation R&D Lab., Pharmaceutical Technology Research Dept., Shionogi & Co., Ltd.
- Yuki Kato, Deputy Review Director, Office of Generic Drugs, Pharmaceuticals and Medical Devices Agency
- Mohammad Salehian, Senior Modelling & Simulation Scientist, CMAC, University of Strathclyde
- Yohei Nishimura, Senior Director, Lean & Digital and Process Execution Team Leader, Japan Operations, AstraZeneca K.K.
- Keisuke Yoshino, Director, Medical Care Solutions Company, Terumo Corp.
- Shin-ichiro Fujiie, President & CEO, PeptiStar Inc.
- Victor Stone, Chief Executive Officer, Alloy Therapeutics Co., Ltd.
- Masayoshi Tsukahara, Head, R&D center, CiRA Foundation
- Keita Mori, CEO, SanBio Co., Ltd.
- Koji Eto, Director & Professor, Center for iPS Cell Research and Application, Kyoto University
- Koki Kitamura, Senior Specialist for Regenerative Medicine, Office for Promotion of Regenerative Medicine, Ministry of Health, Labour and Welfare
Dates, venue and getting there
Interphex Japan 2027 runs 30 June to 2 July 2027 at Tokyo Big Sight. Hours are 10 a.m. to 5 p.m. JST each day, per the official site. In 2026 the show ran 20 to 22 May at Makuhari Messe in Chiba.
Tokyo Big Sight is in Ariake, Koto City. The venue access page puts it about 3 minutes' walk from Tokyo Big Sight Station on the Yurikamome line. Kokusai-Tenjijo Station on the Rinkai Line is about 7 minutes away on foot. Haneda Airport is about 25 minutes away.
The visitor FAQ recommends hotels in the Odaiba and Ariake areas, which visitors book themselves. Visa rules depend on nationality, and show management doesn't help with visa applications. RX Japan also runs COSME Week Tokyo and Medical Japan.
Tickets and registration for Interphex Japan
Entry to Interphex Japan is free, but every visitor must register in advance. Registration for 2027 isn't open yet, and the visit page offers a pre-registration form for alerts.
Badges arrive by email three weeks before the show. Visitors print them in color, and printers are also on site. A badge lets you leave and re-enter during all three days.
It's a business trade show for visitors aged 18 or over. Under-18s need a guardian's consent and must come with an adult, up to five children per adult. Journalists register on the separate press page. We checked these rules in October 2026.
History of Interphex Japan
The 2027 show is the 29th INTERPHEX Week Tokyo and the 9th Regenerative Medicine Expo Tokyo, per the show outline. RX Japan's releases describe the series as more than 20 years old and held every year in Tokyo and Osaka.
Pharma Digital Transformation EXPO launched in 2025. CMO/CDMO EXPO debuted in May 2026 as Japan's only show dedicated to CMOs and CDMOs. The Osaka edition ran 30 September to 2 October 2026 at INTEX Osaka, per the post-show report.
Resources for exhibitors, sponsors and attendees
These official Interphex Japan pages cover planning, exhibiting and visiting.
- Interphex Japan home pageFor dates, hours and the 2027 forecasts.
- Show outlineFor the six shows, the regenerative medicine expo and endorsing bodies.
- Exhibiting information request formFor stand costs, the previous exhibitor list and the floor plan.
- Exhibit page and FAQFor booking rules, rental packages and past visiting companies.
- Visitor pre-registrationTo hear when 2027 registration opens.
- Visitor FAQFor badges, age rules, hotels and the exhibitor directory.
- 2026 exhibitor directoryFor last year's exhibitors and products.
- 2026 post-show reportFor exhibitor and visitor figures, the visitor profile and seminar speakers.
- 2026 conference programFor last year's sessions.
- Venue info and accessFor Tokyo Big Sight transport links.
- Press page and releasesFor media registration and news.